Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Supernus Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
SUPN
Nasdaq
2834
https://www.supernus.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Supernus Pharmaceuticals Inc
Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...
- May 10th, 2024 5:38 pm
Supernus Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.31 in 1Q 2023)
- May 10th, 2024 11:03 am
Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
- May 9th, 2024 8:05 pm
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2024 Earnings Call Transcript
- May 9th, 2024 3:56 pm
Supernus Pharmaceuticals Inc (SUPN) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
- May 9th, 2024 7:42 am
Compared to Estimates, Supernus (SUPN) Q1 Earnings: A Look at Key Metrics
- May 8th, 2024 11:00 pm
Supernus Announces First Quarter 2024 Financial Results
- May 8th, 2024 8:05 pm
M8 Pharmaceuticals, an Acino company, signs an exclusive licensing agreement with Supernus for QelbreeĀ® (Viloxazine XR) in Latin America
- May 7th, 2024 2:00 pm
Ahead of Supernus (SUPN) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
- May 7th, 2024 1:15 pm
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
- May 1st, 2024 12:00 pm
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
- Apr 24th, 2024 8:05 pm
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
- Apr 8th, 2024 4:11 pm
Supernus Provides Regulatory Update for SPN-830
- Apr 8th, 2024 12:00 pm
Supernus to Participate in Two Upcoming Investor Conferences
- Mar 6th, 2024 9:30 pm
11 Best Small Cap Pharma Stocks to Invest In
- Mar 5th, 2024 1:28 am
Supernus Pharmaceuticals Full Year 2023 Earnings: Beats Expectations
- Feb 29th, 2024 11:39 am
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
- Feb 28th, 2024 9:30 pm
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript
- Feb 28th, 2024 2:19 pm
Q4 2023 Supernus Pharmaceuticals Inc Earnings Call
- Feb 28th, 2024 12:17 pm
Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 28th, 2024 12:30 am
Scroll